Cargando…

Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.

In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have...

Descripción completa

Detalles Bibliográficos
Autores principales: Threlfall, E J, Ward, L R
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631792/
https://www.ncbi.nlm.nih.gov/pubmed/11384525
_version_ 1782163986460966912
author Threlfall, E J
Ward, L R
author_facet Threlfall, E J
Ward, L R
author_sort Threlfall, E J
collection PubMed
description In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.
format Text
id pubmed-2631792
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-26317922009-05-20 Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Threlfall, E J Ward, L R Emerg Infect Dis Research Article In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan. Centers for Disease Control and Prevention 2001 /pmc/articles/PMC2631792/ /pubmed/11384525 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Article
Threlfall, E J
Ward, L R
Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
title Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
title_full Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
title_fullStr Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
title_full_unstemmed Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
title_short Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
title_sort decreased susceptibility to ciprofloxacin in salmonella enterica serotype typhi, united kingdom.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631792/
https://www.ncbi.nlm.nih.gov/pubmed/11384525
work_keys_str_mv AT threlfallej decreasedsusceptibilitytociprofloxacininsalmonellaentericaserotypetyphiunitedkingdom
AT wardlr decreasedsusceptibilitytociprofloxacininsalmonellaentericaserotypetyphiunitedkingdom